Scarica l'app Stockscreener
3.5654
1.28%
0.0454
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Precedente Chiudi:
$3.52
Aprire:
$3.47
Volume 24 ore:
541.36K
Relative Volume:
0.26
Capitalizzazione di mercato:
$612.06M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.2734
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
-4.68%
1M Prestazione:
+1.28%
6M Prestazione:
-20.25%
1 anno Prestazione:
-55.38%
Intervallo 1D:
$3.42
$3.61
Intervallo di 1 settimana:
$3.42
$3.88
Portata 52W:
$1.775
$10.72
Relay Therapeutics Inc Stock (RLAY) Company Profile
Nome
Relay Therapeutics Inc
Settore
Industria
Telefono
617-370-8837
Indirizzo
399 BINNEY STREET, CAMBRIDGE
Confronta RLAY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.57 | 622.35M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.80 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
546.64 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.84 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
671.09 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.96 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-17 | Iniziato | Wells Fargo | Equal Weight |
| 2024-09-10 | Ripresa | Goldman | Buy |
| 2024-09-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-04-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Iniziato | Raymond James | Outperform |
| 2023-02-03 | Iniziato | Oppenheimer | Outperform |
| 2022-09-30 | Iniziato | Barclays | Equal Weight |
| 2022-09-02 | Iniziato | Stifel | Buy |
| 2022-06-06 | Iniziato | Jefferies | Underperform |
| 2022-02-01 | Iniziato | Berenberg | Buy |
| 2021-07-21 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-11-05 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-10 | Iniziato | Cowen | Outperform |
| 2020-08-10 | Iniziato | Goldman | Buy |
| 2020-08-10 | Iniziato | Guggenheim | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
Mostra tutto
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Barclays Reiterates a Buy Rating on Relay Therapeutics (RLAY) - Insider Monkey
How does Relay Therapeutics Inc. generate profit in a changing economyDaily Trading Opportunities For Consistent Profits - jammulinksnews.com
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 - The Manila Times
What makes Relay Therapeutics Inc. stock price move sharplyPost Market Recommendation With High Returns - jammulinksnews.com
Rahmer Peter sells Relay Therapeutics (RLAY) stock worth $62,946 By Investing.com - Investing.com Canada
Relay Therapeutics president sells $113k in stock - Investing.com
Relay Therapeutics Executives Sell Shares - TradingView
Published on: 2025-07-29 23:02:46 - metal.it
Relay Therapeutics has positive read from Celcuity data, says Barclays - Yahoo Finance
Published on: 2025-07-29 04:36:35 - beatles.ru
What is the risk reward ratio of investing in Relay Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com
When is Relay Therapeutics Inc. stock expected to show significant growthStock Strategy Tracker With High Returns - jammulinksnews.com
Price Floor Holding on Relay Therapeutics Inc. — Rebound PossibleProfit Focused Stock Screener Results Released - metal.it
What are the technical indicators suggesting about Relay Therapeutics Inc.Achieve breakthrough performance in the market - jammulinksnews.com
Why is Relay Therapeutics Inc. stock attracting strong analyst attentionAchieve breakthrough profits with smart strategies - jammulinksnews.com
What are Relay Therapeutics Inc. company’s key revenue driversGet expert analysis on top stock picks - jammulinksnews.com
Does Relay Therapeutics Inc. stock perform well during market downturnsAchieve breakthrough investment performance - jammulinksnews.com
How does Relay Therapeutics Inc. compare to its industry peersMaximize gains with proven stock analysis - jammulinksnews.com
Is Relay Therapeutics Inc. a growth stock or a value stockGet daily updates on the hottest stocks - jammulinksnews.com
What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Invest in high-yield stocks with confidence - jammulinksnews.com
Is Relay Therapeutics Inc. stock overvalued or undervaluedExplosive capital appreciation - jammulinksnews.com
What are the latest earnings results for Relay Therapeutics Inc.Build wealth steadily with smart stock selection - jammulinksnews.com
Published on: 2025-07-27 23:12:22 - jammulinksnews.com
Why Relay Therapeutics Inc. stock attracts strong analyst attentionFree Stock Investment Growth Plan - metal.it
What analysts say about Relay Therapeutics Inc. stockExceptional growth trajectory - PrintWeekIndia
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? - Yahoo Finance
Is Relay Therapeutics Inc. a good long term investmentFree Investment Community - PrintWeekIndia
When is the best time to buy Relay Therapeutics Inc. stockMassive wealth growth - jammulinksnews.com
Will Relay Therapeutics Inc. stock benefit from AI tech trendsFree Stock Index Interpretation - jammulinksnews.com
What drives Relay Therapeutics Inc. stock priceTremendous growth potential - PrintWeekIndia
Relay Therapeutics Inc. Stock Analysis and ForecastExceptional earning trajectories - jammulinksnews.com
Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Relay Therapeutics Inc Azioni (RLAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
0.39%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):